Two genome-wide association studies (GWAS) performed in primary erythromelalgia patients in 2004 and 2005 revealed gain-of-function mutations in the SCN9A gene [26,27]. Here, SCN9A is linked to sodium channelopathy-related small fiber neuropathy.